Variables | Total | survivor | non-survivor | P-Value |
---|---|---|---|---|
N = 1269 |  N = 1186 |  N = 83 |  | |
Men (n, %) | 843 (66.4%) | 796 (67.1%) | 47 (56.6%) | 0.050 |
Age (y) | 68.8 ± 12.6 | 68.5 ± 12.5 | 73.4 ± 13.0 | < 0.001 |
Ethnicity (white, n, %) | 833 (65.6%) | 795 (67.0%) | 38 (45.8%) | < 0.001 |
length of hospital stay (days) | 122.4 ± 57.9 | 125.0 ± 57.5 | 85.3 ± 50.5 | < 0.001 |
Concomitant disease (n, %) | Â | Â | Â | Â |
Hypertension | 468 (36.9%) | 445 (37.5%) | 23 (27.7%) | 0.073 |
Diabetes mellitus | 539 (42.5%) | 505 (42.6%) | 34 (41.0%) | 0.773 |
Cardiac arrhythmia | 399 (31.4%) | 369 (31.1%) | 30 (36.1%) | 0.340 |
Heart failure | 641 (50.5%) | 597 (50.3%) | 44 (53.0%) | 0.638 |
Pulmonary hypertension | 76 (6.0%) | 73 (6.2%) | 3 (3.6%) | 0.482 |
Chronic pulmonary disease | 119 (9.4%) | 108 (9.1%) | 11 (13.3%) | 0.210 |
Peripheral vascular disease | 130 (10.2%) | 120 (10.1%) | 10 (12.0%) | 0.575 |
Cerebrovascular disease | 50 (3.9%) | 48 (4.0%) | 2 (2.0%) | 0.653 |
Renal disease | 74 (5.8%) | 67 (5.6%) | 7 (8.4%) | 0.421 |
Severe liver disease | 13 (1.0%) | 12 (1.0%) | 1 (1.2%) | 1.000 |
Laboratory metrics | Â | Â | Â | Â |
BUN (mg/dL) | 26.2 ± 19.2 | 25.4 ± 18.7 | 37.9 ± 22.7 | < 0.001 |
Creatinine (mg/dL) | 1.5 ± 1.6 | 1.4 ± 1.5 | 2.1 ± 1.7 | < 0.001 |
Troponin T (ng/mL) | 1.5 ± 3.3 | 1.4 ± 3.0 | 2.7 ± 5.6 | < 0.001 |
CKMB (ng/mL) | 38.9 ± 72.8 | 36.6 ± 69.2 | 68.2 ± 104.9 | < 0.001 |
Glucose (mg/dL) | 149.2 ± 73.2 | 145.4 ± 68.0 | 204.1 ± 114.3 | < 0.001 |
Sodium (mEq/L) | 138.6 ± 4.1 | 138.7 ± 4.0 | 137.3 ± 5.3 | 0.024 |
Potassium (mEq/L) | 4.2 ± 0.6 | 4.2 ± 0.6 | 4.4 ± 0.9 | 0.196 |
RPR | 0.08 ± 0.06 | 0.08 ± 0.06 | 0.11 ± 0.07 | < 0.001 |
Lymphocyte (K/ L) | 16.9 ± 9.8 | 17.2 ± 9.7 | 12.1 ± 9.7 | < 0.001 |
Platelet (K/ L) | 216.8 ± 97.3 | 218.5 ± 97.1 | 193.0 ± 98.4 | 0.021 |
RBC (m/uL) | 3.9 ± 0.8 | 4.0 ± 0.8 | 3.8 ± 0.8 | 0.100 |
RDW (%) | 14.6 ± 1.9 | 14.5 ± 1.8 | 15.5 ± 2.1 | < 0.001 |
Hemoglobin (g/dL) | 11.0 ± 2.3 | 11.0 ± 2.3 | 11.0 ± 2.1 | 0.769 |
MCH (pg) | 30.1 ± 2.3 | 30.1 ± 2.3 | 30.2 ± 2.6 | 0.675 |
MCHC (%) | 33.1 ± 1.5 | 33.2 ± 1.5 | 32.6 ± 1.5 | 0.002 |
MCV (fL) | 90.8 ± 6.2 | 90.7 ± 6.1 | 92.7 ± 7.8 | 0.008 |
Treatments | Â | Â | Â | Â |
PCI | 283 (22.3%) | 272 (22.9%) | 11 (13.3%) | 0.041 |
CABG | 268 (21.1%) | 267 (22.5%) | 1 (1.2%) | < 0.001 |